Editorial: Reviews in cancer metabolism

Editorial: Reviews in cancer metabolism

Bibliographic Details
Main Authors:	Nadia Jacobo-Herrera, Bela Ozsvari
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Oncology
Subjects:	cancer metabolism metabolic therapy metabolic reprogramming resistance mechanisms mitochondria
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1167484/full

Similar Items

Editorial: Reviews in cancer metabolism: 2023
by: Bela Ozsvari, et al.
Published: (2024-09-01)

Editorial: Metabolic reprogramming in breast cancer
by: Cristian Scatena, et al.
Published: (2022-11-01)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
by: Shiqi Nong, et al.
Published: (2023-04-01)

Editorial: Metabolism Meets Function: The Multifaced Role of Metabolism in Cancer
by: Isabella Giacomini, et al.
Published: (2022-05-01)

The Role of Aberrant Metabolism in Cancer: Insights Into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer
by: Yina Yu, et al.
Published: (2020-06-01)

Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer
by: Pengzhu Huang, et al.
Published: (2023-02-01)

Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
by: Kun Huang, et al.
Published: (2025-01-01)

Metabolic Alterations in Canine Mammary Tumors
by: Guilherme Henrique Tamarindo, et al.
Published: (2023-08-01)

Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
by: Soumik Pal, et al.
Published: (2022-12-01)

Targeting oxidative phosphorylation as an approach for the treatment of ovarian cancer
by: Yinjie Wu, et al.
Published: (2022-09-01)

Nanotechnology-based tumor metabolic reprogramming: Insights into nutrient-delivery and metabolism reactivation therapy
by: Xi Hu, et al.
Published: (2024-10-01)

Metabolic Reprogramming, Questioning, and Implications for Cancer
by: Pierre Jacquet, et al.
Published: (2021-02-01)

A mini-review-cancer energy reprogramming on drug resistance and immune response
by: Chengxiang Liu, et al.
Published: (2024-11-01)

Editorial: Metabolic reprogramming in cancer
by: Valentina Audrito, et al.
Published: (2025-03-01)

Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib<sup>+</sup>
by: Nicla Lorito, et al.
Published: (2020-03-01)

Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance
by: Hamid Aria, et al.
Published: (2022-08-01)

Metabolic reprogramming of three major nutrients in platinum-resistant ovarian cancer
by: Jinbowen Yan, et al.
Published: (2023-08-01)

Breast Cancer Cell Subtypes Display Different Metabolic Phenotypes That Correlate with Their Clinical Classification
by: Consuelo Ripoll, et al.
Published: (2021-12-01)

Exploring the significance of fatty acid metabolism reprogramming in the pathogenesis of cancer and anticancer therapy
by: Jiaao Sun, et al.
Published: (2025-12-01)

Editorial: Rising stars in cancer metabolism 2022
by: Jose Luis Izquierdo-Garcia, et al.
Published: (2023-05-01)

MiRNAs Action and Impact on Mitochondria Function, Metabolic Reprogramming and Chemoresistance of Cancer Cells: A Systematic Review
by: Daiane Rosolen, et al.
Published: (2023-02-01)

TIMM9 as a prognostic biomarker in multiple cancers and its associated biological processes
by: Lisheng Zhang, et al.
Published: (2024-09-01)

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy
by: Jiaqi Li, et al.
Published: (2020-10-01)

MicroRNAs in metabolism for precision treatment of lung cancer
by: Giovanna Carrà, et al.
Published: (2024-09-01)

Editorial: Metabolic Abnormalities and Breast Cancer: Challenges From Bench to Bedside
by: Zheng Wang, et al.
Published: (2022-04-01)

Aiding Cancer’s “Sweet Tooth”: Role of Hexokinases in Metabolic Reprogramming
by: Zeenat Farooq, et al.
Published: (2023-04-01)

Metabolic reprogramming in colorectal cancer: regulatory networks and therapy
by: Jieping Zhang, et al.
Published: (2023-02-01)

Editorial: Linking cellular metabolism to hematological malignancies
by: Xiujing He, et al.
Published: (2022-11-01)

The Development of Single-Cell Metabolism and Its Role in Studying Cancer Emergent Properties
by: Dingju Wei, et al.
Published: (2022-01-01)

Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer
by: Macus Hao-Ran Bao, et al.
Published: (2021-07-01)

The role of metabolic reprogramming in kidney cancer
by: Ziyi Chen, et al.
Published: (2024-05-01)

Regulation of Glucose, Fatty Acid and Amino Acid Metabolism by Ubiquitination and SUMOylation for Cancer Progression
by: Shunqin Zhu, et al.
Published: (2022-03-01)

The Intersection of Purine and Mitochondrial Metabolism in Cancer
by: Humberto De Vitto, et al.
Published: (2021-09-01)

Metabolic reprogramming in lung cancer and its clinical implication
by: Qingqiu Huang, et al.
Published: (2024-12-01)

Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
by: Xun Chen, et al.
Published: (2020-07-01)

The role of acetylation and deacetylation in cancer metabolism
by: Cuicui Wang, et al.
Published: (2025-01-01)

Targeting Mitochondrial Metabolism as a Strategy to Treat Senescence
by: Yun Haeng Lee, et al.
Published: (2021-11-01)

Targeting RNA‐binding motif protein 39 for arginine reduction: unveiling metabolic vulnerability in arginine‐dependent liver cancer
by: Aoxue Li, et al.
Published: (2024-07-01)

Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells
by: Yuchuan Yang, et al.
Published: (2023-12-01)

Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism
by: Pei Lin, et al.
Published: (2024-06-01)